IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

ABG Innovation Capital Partners III GP Ltd

Q4 2020 Holdings

Filed 2021-02-16 | 7 holdings | $110.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Atea Pharmaceuticals Inc(AVIR)COM04683R106$110.3M2,639,17899.9%
Pulmonx Corp(LUNG)COM745848101$57.5K833,3330.1%
Genocea Biosciences Inc(GNCAQ)COM NEW372427401$908375,0000.0%
Synlogic IncCOM87166L100$445205,9060.0%
Aerpio Pharmaceuticals IncCOM00810B105$392400,0000.0%
Idera Pharmaceuticals IncCOM PAR45168K405$20656,2500.0%
Nabriva Therapeutics PLCSHS NEWG63637113$11145,8490.0%